Cargando…
Inhibition effect of pyridoxamine on lipid hydroperoxide-derived modifications to human serum albumin
Pyridoxamine (PM) is a promising drug candidate for treating various chronic conditions/diseases in which oxidative stress and carbonyl compounds are important factors affecting pathogenicity. These abilities of PM are mainly attributed to its inhibition of advanced glycation and lipoxidation end pr...
Autores principales: | Lee, Seon Hwa, Matsunaga, Atsushi, Oe, Tomoyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908094/ https://www.ncbi.nlm.nih.gov/pubmed/29672562 http://dx.doi.org/10.1371/journal.pone.0196050 |
Ejemplares similares
-
Complexes of Copper and Iron with Pyridoxamine, Ascorbic Acid, and a Model Amadori Compound: Exploring Pyridoxamine’s Secondary Antioxidant Activity
por: García-Díez, Guillermo, et al.
Publicado: (2021) -
Lipid hydroperoxides in nutrition, health, and diseases
por: MIYAZAWA, Teruo
Publicado: (2021) -
Preventive Effect of Salicylate and Pyridoxamine on Diabetic Nephropathy
por: Abouzed, Tarek Kamal, et al.
Publicado: (2016) -
Pyridoxamine: another vitamin for sickle cell disease?
por: Telen, Marilyn J.
Publicado: (2020) -
Pathophysiological potential of lipid hydroperoxide intermembrane translocation: Cholesterol hydroperoxide translocation as a special case
por: Girotti, Albert W., et al.
Publicado: (2021)